Schedule 13D ownership disclosure

Ironwood Pharmaceuticals Inc

Security class unavailable · CUSIP: 46333X108

Event date: 2020-02-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,493,000
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000196
Form type
SC 13D/A
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Feb 26, 2020
Reporting period
Feb 25, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub